Status of implementation and organization of cancer screening in The European Union Member StatesSummary results from the second European screening report
Status of implementation and organization of cancer screening in The European Union Member StatesSummary results from the second European screening report
复制标题
DOI：
10.1002/ijc.31043
复制
发表时间：
2018-01-01
影响因子：
6.4
通讯作者：
Sankaranarayanan, Rengaswamy
中科院分区：
文献类型：
--
作者：
Basu, Partha;Ponti, Antonio;Sankaranarayanan, Rengaswamy
关于欧盟（EU）癌症筛查实施状况的第二份报告于2017年发布。该报告描述了欧盟乳腺癌、宫颈癌和结直肠癌筛查的实施状况、方案和组织（更新至2016年）以及邀请覆盖范围（2013年索引年）。来自欧盟成员国的筛查规划监测专家（N=80）在各自国家获得必要的信息，通过在线问卷提供了乳腺癌、宫颈癌和结直肠癌筛查的数据。收集的数据仅用于在公共授权方案框架内进行的筛查。调查问卷来自26个会员国，涉及所有三个地点，其中一个会员国只涉及乳腺癌。采用基于人群的方法，在筛查实施方面有了实质性的改进。在符合年龄条件的妇女中，94.7%是2016年实施或计划基于人群的乳腺癌筛查的会员国的居民，而2007年为91.6%。在2016年及2007年，子宫颈癌普查的相应数字分别为72.3%及51.3%。2016年，有17个会员国正在或完成了结直肠癌筛查，而2007年只有5个会员国取得了最显著的进展。因此，在符合年龄条件的人群中，2016年有72.4%的人接受了基于人群的筛查，而2007年只有42.6%。邀请覆盖率变化很大，在目标人群中，乳腺癌的覆盖率为0.2-111%，宫颈癌的覆盖率为7.6-105%，结直肠癌的覆盖率为1.8-127%。尽管取得了相当大的进展，但仍有许多工作要做，以达到最佳效果。需要继续监测、定期反馈和定期报告，以确保方案产生预期的影响。有什么新鲜事吗?2003年，欧盟（EU）理事会敦促成员国更加重视乳腺癌、宫颈癌和结直肠癌的筛查。第二份关于这方面进展的报告于2017年发布。本手稿详细介绍了成员国筛查计划的实施状况、方案和组织以及筛查邀请覆盖的目标人群。数据显示，在10年内，获得乳腺癌、宫颈癌和结直肠癌筛查的合格欧盟人口比例分别增加了5.8%、11.9%和33.6%。理事会今后的建议可能需要考虑纳入其他筛查策略。
The second report on the implementation status of cancer screening in European Union (EU) was published in 2017. The report described the implementation status, protocols and organization (updated till 2016) and invitation coverage (for index year 2013) of breast, cervical and colorectal cancer screening in the EU. Experts in screening programme monitoring (N=80) from the EU Member States having access to requisite information in their respective countries provided data on breast, cervical and colorectal cancer screening through online questionnaires. Data was collected for screening performed in the framework of publicly mandated programmes only. Filled in questionnaires were received from 26 Member States for all three sites and from one Member State for breast cancer only. Substantial improvement in screening implementation using population-based approach was documented. Among the age-eligible women, 94.7% were residents of Member States implementing or planning population-based breast cancer screening in 2016, compared to 91.6% in 2007. The corresponding figures for cervical cancer screening were 72.3 and 51.3% in 2016 and 2007, respectively. Most significant improvement was documented for colorectal cancer screening with roll-out ongoing or completed in 17 Member States in 2016, compared to only five in 2007. So the access to population-based screening increased to 72.4% of the age-eligible populations in 2016 as opposed to only 42.6% in 2007. The invitation coverage was highly variable, ranging from 0.2-111% for breast cancer, 7.6-105% for cervical cancer and 1.8-127% for colorectal cancer in the target populations. In spite of the considerable progress, much work remains to be done to achieve optimal effectiveness. Continued monitoring, regular feedbacks and periodic reporting are needed to ensure the desired impacts of the programmes.What's new? In 2003 the European Union (EU) Council urged member states to devote greater attention to breast, cervical, and colorectal cancer screening. The second report on progress in this regard was published in 2017. The present manuscript details implementation status, protocol, and organization of screening programs and screening invitation coverage of target populations in member states. The data show that within a decade, the proportion of eligible EU populations having access to breast, cervical, and colorectal cancer screening increased by 5.8, 11.9 and 33.6 percent respectively. Future Council recommendations may need to consider the incorporation of alternative screening strategies.